Funding for this research was provided by:
DR. KADE Pharmazeutische Fabrik GmbH
Article History
Received: 24 November 2020
Accepted: 17 March 2021
First Online: 27 March 2021
Change Date: 15 May 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00404-021-06093-9
Declarations
:
: Author R Diebold is an employee of DR. KADE Pharmazeutische Fabrik GmbH, Berlin, Germany and received support in form of salary. The authors B Schopf and H Stammer are employees of the Clinical Research Organistation Pharmalog Institut für klinische Forschung GmbH, which was contracted by DR. KADE. The scientific study coordinator W Mendling received honorarium for this work as well as speaker honoraria at scientific training events organized by the funder.
: Due to the observational character of the study, no formal ethic vote was necessary. In accordance with article 15(1) of the model professional code for physicians in Germany, all study-relevant documents were approved by the ethic committee (ethics commission of the Bavarian medical association, Munich).
: Prior to inclusion, a written informed consent was obtained from each participant.
: All authors agreed to the publication.